Polymerase fidelity of E89G, a nucleoside analog-resistant variant of human immunodeficiency virus type 1 reverse transcriptase

被引:56
作者
Drosopoulos, WC [1 ]
Prasad, VR [1 ]
机构
[1] ALBERT EINSTEIN COLL MED,DEPT MICROBIOL & IMMUNOL,BRONX,NY 10461
关键词
D O I
10.1128/JVI.70.7.4834-4838.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Nucleoside analog resistance in human immunodeficiency virus type I results from mutations in reverse transcriptase (RT) that allow the enzyme to discriminate against such analogs, To evaluate the possible impact of such mutations on the ability of human immunodeficiency virus RT to selectively incorporate Watson-Crick base-paired deoxynucleotide triphosphates (dNTPs) over incorrectly paired dNTPs, we have measured the fidelity of dNTP insertion by the E89G variant of RT in in vitro reaction mixtures containing synthetic template primers. The E89G RT was previously shown to be resistant to several ddNTPs and to phosphonoformic acid, Our results show that the mutant enzyme displays a lower le, el of efficiency of misinsertion than did the wild-type RT for every mispair tested (ranging from 2- to 17-fold).
引用
收藏
页码:4834 / 4838
页数:5
相关论文
共 41 条
[1]  
BEARD WA, 1994, J BIOL CHEM, V269, P28091
[2]   REDUCED FRAMESHIFT FIDELITY AND PROCESSIVITY OF HIV-1 REVERSE-TRANSCRIPTASE MUTANTS CONTAINING ALANINE SUBSTITUTIONS IN HELIX-H OF THE THUMB SUBDOMAIN [J].
BEBENEK, K ;
BEARD, WA ;
CASASFINET, JR ;
KIM, HR ;
DARDEN, TA ;
WILSON, SH ;
KUNKEL, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (33) :19516-19523
[3]  
BEBENEK K, 1989, J BIOL CHEM, V264, P16948
[4]  
BEBENEK K, 1993, REVERSE TRANSCRIPTAS, P85
[5]  
BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689
[6]   SENSITIVITY OF WILD-TYPE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE TO DIDEOXYNUCLEOTIDES DEPENDS ON TEMPLATE LENGTH - THE SENSITIVITY OF DRUG-RESISTANT MUTANTS DOES NOT [J].
BOYER, PL ;
TANTILLO, C ;
JACOBOMOLINA, A ;
NANNI, RG ;
DING, JP ;
ARNOLD, E ;
HUGHES, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4882-4886
[7]  
CHENG YC, 1987, J BIOL CHEM, V262, P2187
[8]  
Cleland W W, 1979, Methods Enzymol, V63, P103
[9]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[10]  
Creighton S, 1995, METHOD ENZYMOL, V262, P232